IMMUCELL CORP /DE/ (ICCC): debt financing — ImmuCell extends $1M line of credit with Maine Community Bank to Sept 2026

IMMUCELL CORP /DE/

$1M line of credit extended through September 11, 2026.
Interest on borrowings is variable at the National Prime Rate per annum.
Original line of credit dated March 11, 2020, unchanged except maturity.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

IMMUCELL CORP /DE/ amended revolving credit of $1 million line of credit with Maine Community Bank (MCB) at variable at the National Prime Rate per annum maturing September 11, 2026.

Instrument: revolving credit
Principal: $1 million line of credit
Counterparty: Maine Community Bank (MCB)
Rate: variable at the National Prime Rate per annum
Maturity: September 11, 2026
Event: amendment

Exact text from the filing

On August 20, 2025, ImmuCell Corporation (the “Company”) entered into an Allonge to and Amendment of Line of Credit (the “Allonge”) between the Company and Maine Community Bank (MCB) pursuant to which the Company’s $1 million line of credit with MCB was extended through September 11, 2026. Interest on borrowings against the Line of Credit is variable at the National Prime Rate per annum.

View on SEC.gov

Browse all debt financings →

IMMUCELL CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001213900-25-080110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.